Balyasny Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,428
Closed -$1.91M 2933
2022
Q4
$1.91M Hold
9,428
0.01% 1451
2022
Q3
$1.66M Buy
9,428
+7,100
+305% +$1.45M 0.01% 1583
2022
Q2
$469K Buy
+2,328
New +$496K ﹤0.01% 1998
2017
Q2
Sell
-69,840
Closed -$8.61M 1616
2017
Q1
$8.61M Buy
+69,840
New +$8.27M 0.04% 546
2016
Q3
Sell
-34,920
Closed -$3.91M 1149
2016
Q2
$3.91M Buy
+34,920
New +$3.76M 0.03% 563

Other funds holding LH

Balyasny Asset Management's LH Position: Q1 2026 in Review

Balyasny Asset Management reduced its Labcorp (LH) stake by 50% in Q1 2026, selling an estimated $6.19M and leaving 22,522 shares worth $6.01M. The position accounts for 0.01% of the portfolio, ranked #1278.

Balyasny Asset Management first reported a position in LH in Q2 2013 and has held it in 31 quarters since. The position peaked at $133M in Q4 2014. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Balyasny Asset Management held 22,522 shares of Labcorp worth $6.01M as of Q1 2026.
  • Balyasny Asset Management sold 22,878 Labcorp shares in Q1 2026, an estimated $6.19M.
  • Labcorp made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1278 holding.
  • Balyasny Asset Management first reported a position in Labcorp in Q2 2013 and has held it in 31 quarters since.
  • Balyasny Asset Management's Labcorp position peaked at $133M in Q4 2014.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.